Analysis – Page 26 – Goldea Capital

EssilorLuxottica signs an agreement to acquire A-Look, Seen and OWL retail stores in Malaysia

Written by Customer Service on June 5, 2025. Posted in Mergers And Acquisitions.

EssilorLuxottica signs an agreement to acquireA-Look, Seen and OWL retail stores in Malaysia With this transaction, the Group aims at further elevating the standards of vision care in the country Paris, France (5 June 2025) – EssilorLuxottica announces today it has signed an agreement for the acquisition of one of the largest optical companies in Malaysia operating over 90 stores under the A-Look, Seen and OWL banners. A-Look was founded in 2003 by Dato Terry Ngeow, with the opening of its inaugural store in Kuala Lumpur, Malaysia. At present, A-Look, Seen and OWL stores are located across East and West (or Peninsular) Malaysia. With the acquisition of these renowned omnichannel and multi-branded stores, EssilorLuxottica aims at complementing its long-standing position in Malaysia, where the Group is currently present with both wholesale...

IDEX Biometrics ASA: Last day of the subscription period in the subsequent offering

Written by Customer Service on June 5, 2025. Posted in Public Companies.

Reference is made to the stock exchange notice from IDEX Biometrics ASA on 21 May 2025 regarding the subscription period (the “Subscription Period”) in the subsequent offering (the “Subsequent Offering”) consisting of up to 600 million new shares at a subscription price of NOK 0.01 per share (“Offer Shares”). The Subscription Period will end today, 5 June 2025, at 16:30 CET. This Subsequent Offering is conducted to give the shareholders not participating in the debt conversion on 11 April 2025 an opportunity to subscribe for Offer Shares at a subscription price per share equal to the subscription price in the debt conversion. Completed subscription forms must be received by Arctic Securities AS, or, in the case of online subscriptions, be registered by the expiry of the Subscription Period. Subscription rights that...

[Valneva SE] Declaration of shares and voting rights – May 2025

Written by Customer Service on June 5, 2025. Posted in Public Companies.

VALNEVA Declaration of shares and voting rights May 31, 2025__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris – Compartment B Declaration date: June 5, 2025Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights** 170,188,190 ordinary shares with a par value of €0.15 each 186,313,236 Double voting rights granted on 236,308 ordinary shares Capital increase without preferential subscription rights (2,916,666 new ordinary...

VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION

Written by Customer Service on June 5, 2025. Posted in Public Companies.

Press Release VALLOUREC OBTAINS THE QUALIFICATION OF ITS HYDROGEN STORAGE SOLUTION AND LAUNCHES COMMERCIALIZATION Meudon (France), June 5, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the official qualification of Delphy, its vertical gaseous hydrogen storage solution, by DNV. A world first, Delphy enables the storage of 1 to 100 tons of hydrogen under maximum safety conditions. Thanks to its minimal footprint, this vertical system – extending up to 100 meters underground – meets the challenge of complex and demanding industrial environments. It targets both green hydrogen producers and industrial players such as synthetic fuel producers (e-SAF, e-methanol), green ammonia producers, steelmakers, and refineries. The Delphy solution is the result of Vallourec’s longstanding expertise...

Planisware expands into Belgium to support the sustained growth of its business in the Benelux region

Written by Customer Service on June 5, 2025. Posted in Public Companies.

Planisware expands into Belgium to support the sustained growth of its business in the Benelux region Paris, France, June 5, 2025 – Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, continues its international expansion with the opening of a new office in Belgium. Planisware has been present in the Benelux region for several years, through projects carried out for leading clients such as Galapagos, KLM, Philips, and Engie, and is now consolidating its position in this strategic, fast-growing market. In particular, the Group has seen a sharp increase in its business in this market, with revenue doubling over the last four years, testifying to the relevance of its expertise and the confidence of its customers. This new location is primarily intended to strengthen proximity to Planisware’s customers...

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference

Written by Customer Service on June 5, 2025. Posted in Public Companies.

Geneva, Switzerland, June 5, 2025 – Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that preclinical data from its gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) cough program will be presented at the 10th American Cough Conference (June 6-7) in Dulles, VA. A presentation given by Mikhail Kalinichev, Head of Translational Science at Addex will describe the progress seen to date with the Addex GABAB PAM cough program, including antitussive data from in vivo models. Addex lead drug candidate is ready to start IND enabling studies. Details of the Presentation Date: Saturday, June 7, 2025Time: 11:20 am ESTTitle: ...

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea

Written by Customer Service on June 5, 2025. Posted in Public Companies.

Allschwil, Switzerland, June 05, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the sales threshold triggering the second USD 2.5 million milestone payment this year. David Veitch, Basilea’s Chief Executive Officer, stated: “This milestone payment for the Asia Pacific region, including China, reflects the strong and growing global demand for novel antifungal therapies. Continued growth of Cresemba, particularly in China, where uptake has been especially robust, reinforces its significant clinical value for patients...

MoneyHero and RCBC Forge Strategic Partnership to Tap into the Philippines’ Expanding Card Market

Written by Customer Service on June 5, 2025. Posted in Public Companies.

SINGAPORE, June 04, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (MoneyHero” or the “Company”), a leading personal finance aggregation and comparison platform, as well as a digital insurance brokerage provider in Greater Southeast Asia, today announced a strategic partnership with Rizal Commercial Banking Corporation (“RCBC”), a trusted leader in Philippine banking known for its customer-focused innovation and inclusive financial services, through its card servicing entity, RCBC Bankard Services Corporation (“RCBC Credit Cards”). Through this collaboration, MoneyHero will integrate RCBC’s full suite of rewards, lifestyle, travel, and premium credit card products into its digital platform, enabling Filipinos to seamlessly discover, compare, and apply for cards that suit their personal financial needs. This partnership...

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

Written by Customer Service on June 5, 2025. Posted in Public Companies.

NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of its public offering of an aggregate of 2,768,600 shares of its Class A common stock (or common stock equivalents), and warrants to purchase up to 2,768,600 shares of common stock, at a combined public offering price of $3.27 per share and accompanying warrants. Each Warrant will expire two and one-half (2.5) years from the issuance, will be immediately exercisable upon issuance at an initial exercise price of $7.3575 per share, subject to adjustment on the First Reset Date and the Second Reset Date (as defined in the warrants) and subject to a floor price therein....

Vortex Energy Corp. Announces Conversion of Debentures

Written by Customer Service on June 5, 2025. Posted in Dividend Reports And Estimates.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) announces the conversion of outstanding unsecured convertible debentures of the Company (the “Debentures”) pursuant to notices of conversion received from all holders of the Debentures (the “Conversion”). On January 28, 2025, the Company issued the Debentures for an aggregate principal amount of C$400,000. Interest accrued thereon at a rate of 10% per annum until June 3, 2025, resulting in an aggregate of C$413,916.36 (the “Principal and Interest”) payable by the Company. To satisfy the Principal and Interest, the Company will be issuing an aggregate of 1,061,324 units of the Company (the...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals